FAMTOZINAMERAN
UNII JSV288Q5CV

Substance Identification & Data

This profile provides standardized clinical and technical data for Famtozinameran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) JSV288Q5CV.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
JSV288Q5CV
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
FAMTOZINAMERAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12809
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Famtozinameran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FAMTOZINAMERAN

Common Names & Synonyms

BNT162B2 OMICRON (BA.4/BA.5) MRNA
FAMTOZINAMERAN [INN]
FAMTOZINAMERAN [WHO-DD]
RNA (RECOMBINANT 5'-(1,2-((3'-O-METHYL)M7G-(5'->5')-PPP-AM))-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN SECRETORY SIGNAL PEPTIDE PLUS CODON-OPTIMIZED PRE-FUSION SPIKE GLYCOPROTEIN B.1.1.529.4 AND B.1.1.529.5 VARIANT (986-PROLINE,987-PROLINE)-SPECIFYING PLUS 5'-AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGER RBP020.22), INNER SALT

Technical Codes

BNT162B2 OMICRON (BA.4/BA.5)